Polypharmacy cut-points in older people with cancer: how many medications are too many?

[1]  L. Fratiglioni,et al.  Correction: Age-Related Variation in Health Status after Age 60 , 2015, PloS one.

[2]  M. Tattersall,et al.  Geriatric assessment of older patients with cancer in Australia--a multicentre audit. , 2015, Journal of geriatric oncology.

[3]  Laura Fratiglioni,et al.  Age-Related Variation in Health Status after Age 60 , 2015, PloS one.

[4]  A. Deal,et al.  Geriatric assessment as an aide to understanding falls in older adults with cancer , 2015, Supportive Care in Cancer.

[5]  Paul Gallagher,et al.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.

[6]  J. Lees,et al.  Potentially inappropriate medication use in older people with cancer: prevalence and correlates. , 2014, Journal of geriatric oncology.

[7]  R. Payne,et al.  Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. , 2014, British journal of clinical pharmacology.

[8]  J. Bell,et al.  Prevalence and factors associated with polypharmacy in older people with cancer , 2014, Supportive Care in Cancer.

[9]  J. Lees.  Management of polypharmacy in older cancer patients , 2013 .

[10]  A. Weiss,et al.  Rates, variability, and associated factors of polypharmacy in nursing home patients , 2013, Clinical interventions in aging.

[11]  M. Steinman,et al.  Polypharmacy and the management of the older cancer patient. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  Emily Reeve,et al.  People's Attitudes, Beliefs, and Experiences Regarding Polypharmacy and Willingness to Deprescribe , 2013, Journal of the American Geriatrics Society.

[13]  L. Chew,et al.  The impact of medication therapy management in older oncology patients , 2013, Supportive Care in Cancer.

[14]  S. Hartikainen,et al.  Analgesic Use and Frailty among Community-Dwelling Older People , 2013, Drugs & Aging.

[15]  Danijela Gnjidic,et al.  Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. , 2012, Journal of clinical epidemiology.

[16]  Y. Ouchi,et al.  Polypharmacy as a risk for fall occurrence in geriatric outpatients , 2012, Geriatrics & gerontology international.

[17]  R. Sulkava,et al.  Sedative Load Among Community-Dwelling People Aged 75 Years or Older: Association With Balance and Mobility , 2012, Journal of clinical psychopharmacology.

[18]  C. Campanelli.  American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2012 .

[19]  F. Blyth,et al.  High‐Risk Prescribing and Incidence of Frailty Among Older Community‐Dwelling Men , 2012, Clinical pharmacology and therapeutics.

[20]  H. Cohen,et al.  Senior adult oncology clinical practice guidelines in oncology. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[21]  J. Hanlon,et al.  Prevalence of Unplanned Hospitalizations Caused by Adverse Drug Reactions in Older Veterans , 2012, Journal of the American Geriatrics Society.

[22]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[23]  Judith E. Fisher,et al.  Preventive medication use among persons with limited life expectancy , 2011, Progress in palliative care.

[24]  A. Ring,et al.  The treatment of co-morbidities in older patients with metastatic cancer , 2010, Supportive Care in Cancer.

[25]  Göran Petersson,et al.  Dispensed drugs and multiple medications in the Swedish population: an individual-based register study , 2009, BMC clinical pharmacology.

[26]  Jennifer Tam-Mcdevitt.  Polypharmacy, aging, and cancer. , 2008, Oncology.

[27]  Marcus D. Ruopp,et al.  Youden Index and Optimal Cut‐Point Estimated from Observations Affected by a Lower Limit of Detection , 2008, Biometrical journal. Biometrische Zeitschrift.

[28]  A. Egberts,et al.  Relationship between polypharmacy and underprescribing. , 2007, British journal of clinical pharmacology.

[29]  N. Cook.  Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.

[30]  H. Cohen,et al.  Developing a cancer‐specific geriatric assessment , 2005, Cancer.

[31]  A. Wu,et al.  Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. , 2005, JAMA.

[32]  Justin Beilby,et al.  Collaborative medication management services: improving patient care , 2002, The Medical journal of Australia.

[33]  L. Bouter,et al.  Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. , 2001, Journal of clinical epidemiology.

[34]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[35]  V. Lorusso,et al.  Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  H. S. Lau,et al.  The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. , 2000, British journal of clinical pharmacology.

[37]  F. Haaijer-Ruskamp,et al.  The development of polypharmacy. A longitudinal study. , 2000, Family practice.

[38]  Carol A. Trujillo,et al.  The MOS 36-Item Short Form Health Survey: reliability, validity, and preliminary findings in schizophrenic outpatients. , 1998, Medical care.

[39]  Corcoran,et al.  Polypharmacy in the Older Patient With Cancer. , 1997, Cancer control : journal of the Moffitt Cancer Center.

[40]  M. Corcoran.  Polypharmacy in the Older Patient with Cancer: The plethora of medications taken by older patients with cancer increases the risk of harmful drug interactions. , 1997 .

[41]  H. Cohen,et al.  A method for assessing drug therapy appropriateness. , 1992, Journal of clinical epidemiology.

[42]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[43]  C. Maycock,et al.  Assessment of elderly people in general practice , 1991 .

[44]  G. Fillenbaum,et al.  The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. , 1981, Journal of gerontology.

[45]  S. Wallerstedt,et al.  PHARMACOEPIDEMIOLOGYAND PRESCRIPTION Number of drugs in the medication list as an indicator of prescribing quality: a validation study of polypharmacy indicators in older hip fracture patients , 2015 .

[46]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[47]  J. Hallas,et al.  Polypharmacy and drug use in elderly Danish cancer patients during 1996 to 2006 , 2012 .

[48]  R. Sulkava,et al.  Polypharmacy Status as an Indicator of Mortality in an Elderly Population , 2009, Drugs & aging.

[49]  S. Iliffe,et al.  Assessment of elderly people in general practice. 2. Functional abilities and medical problems. , 1991, The British journal of general practice : the journal of the Royal College of General Practitioners.

[50]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[51]  John G. Orme,et al.  Factorial and discriminant validity of the Center for Epidemiological Studies Depression (CES-D) scale. , 1986, Journal of clinical psychology.

[52]  D. Karnofsky.  The clinical evaluation of chemotherapeutic agents in cancer , 1949 .